Friday Nov 29
Will a nerve cut end post-herpetic neuralgia?
Dear Dr. Roach: I am 85 and in fairly good health, but I am in my ninth year of extremely painful post-herpetic neuralgia.
Brain imaging reveals dynamic changes caused by pain medicines
A study in the December issue of Anesthesiology suggests a role for brain imaging in the assessment and potential treatment of chronic pain.
Green Bay Press-Gazette
Cut the nerve end, end the pain?
Instead of diminishing, the pain is increasing. It could be that the gabapentin is wearing off.
It's Time To Buy Tonix Pharmaceuticals
Tonix Pharmaceuticals is developing TNX-102SL, a sublingual formulation of cyclobenzaprine for the treatment of fibromyalgia syndrome.
Zalicus' Z160 Fails, What Now?
This morning, Zalicus, Inc. released some very unfortunate news for investors holding the stock.
Report: Generics Will Constrain Growth of Neuropathic Pain Drug Market
Decision Resources, a research and advisory firm located in Burlingon, Mass., finds that the loss of U.S. and European market exclusivity of three sales-leading drugs for neuropathic pain - delayed-release duloxetine , lidocaine dermal patch , and pregabalin - combined with a lack of transformative emerging therapies forecasted to launch ... (more)